A61K 31/4155
Non condensed and containing further heterocyclic rings
Official title: non condensed and containing further heterocyclic rings
A61K31/4155 (Non condensed and containing further heterocyclic rings) appears on 892 US grants and 1,624 published applications in this corpus.
Search patents in A61K- Granted patents
- 892
- Published applications
- 1,624
- Assignees
- 708
- Inventors
- 4,109
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 6 | 12 |
| 2003 | 4 | 15 |
| 2004 | 6 | 22 |
| 2005 | 11 | 20 |
| 2006 | 16 | 10 |
| 2007 | 6 | 8 |
| 2008 | 6 | 27 |
| 2009 | 5 | 20 |
| 2010 | 12 | 32 |
| 2011 | 13 | 46 |
| 2012 | 14 | 42 |
| 2013 | 32 | 65 |
| 2014 | 52 | 74 |
| 2015 | 59 | 94 |
| 2016 | 75 | 130 |
| 2017 | 81 | 81 |
| 2018 | 69 | 101 |
| 2019 | 63 | 90 |
| 2020 | 68 | 89 |
| 2021 | 59 | 102 |
| 2022 | 49 | 95 |
| 2023 | 38 | 90 |
| 2024 | 50 | 123 |
| 2025 | 51 | 124 |
| 2026 | 39 | 112 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Combination therapies of FASN inhibitors with thyroid hormone receptor agonists29 Sep 2026US 12,746,242 B2Sagimet Biosciences Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Kinase inhibitors for the treatment of neurodegenerative diseases29 Sep 2026US 12,747,234 B2Ohio State Innovation Foundation
- Pyrazolyl compounds as KV7 channel activators29 Sep 2026US 12,747,237 B2
- Use of small molecules to increase hypoxia inducible factor (hif) activity8 Oct 2026US 2026/0306440 A1Brown University
- Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof1 Oct 2026US 2026/0294884 A1Insilico Medicine IP Limited
- Cyclopentylpyrazolamine derivative and use thereof1 Oct 2026US 2026/0297069 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Bicyclic compounds as cdk inhibitors1 Oct 2026US 2026/0297080 A1BeOne Medicines I GmbH
Most cited
By later US patents
- Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof170US 7,074,801 B1Eisai Co., Ltd. · 2006
- Pyrazole compositions useful as inhibitors of ERK126US 6,784,195 B2Vertex Pharmaceuticals Incorporated · 2004
- 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents110US 6,218,418 B1Pharmacia & Upjohn Company · 2001
- Neprilysin inhibitors77US 8,513,244 B2Theravance, Inc. · 2013
- Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK167US 9,498,467 B2Incyte Corporation · 2016